Mobile Site ›
Print Friendly View

Test ID: HLA57    
HLA-B 5701 Genotype, Abacavir Hypersensitivity, Blood

Secondary ID A test code used for billing and in test definitions created prior to November 2011

89346

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Assisting a physician in developing a therapeutic management strategy for HIV-infected patients

 

Predicting likelihood of hypersensitivity reactions to abacavir in HIV-infected patients, based on the presence of the human leukocyte antigen HLA-B*5701 allele

 

Aiding in differentiating between true hypersensitivity to abacavir versus other underlying causes (eg, concomitant infection, reaction to other drugs, or inflammatory disease)

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Abacavir Hypersensitivity Testing and Initial Patient Management Algorithm in Special Instructions

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Qualitative Allele-Specific Real-Time Polymerase Chain Reaction (PCR)

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

HLA-B 5701 Genotype, Abacavir, B

Aliases Lists additional common names for a test, as an aid in searching

Abacavir Hypersensitivity
HLA B
HLA B57
HLA B5701
HLA-B57
HLA-B57.1
HLAB
HLAB5701